Sato Kenji, Li Yong, Foster William, Fukushima Kazumasa, Badlani Neil, Adachi Nobuo, Usas Arvydas, Fu Freddie H, Huard Johnny
Growth and Development Laboratory, Department of Orthopaedic Surgery, Children's Hospital, Pittsburgh, Pennsylvania, USA.
Muscle Nerve. 2003 Sep;28(3):365-72. doi: 10.1002/mus.10436.
Skeletal muscle is able to repair itself through regeneration. However, an injured muscle often does not fully recover its strength because complete muscle regeneration is hindered by the development of fibrosis. Biological approaches to improve muscle healing by enhancing muscle regeneration and reducing the formation of fibrosis are being investigated. Previously, we have determined that insulin-like growth factor-1 (IGF-1) can improve muscle regeneration in injured muscle. We also have investigated the use of an antifibrotic agent, decorin, to reduce muscle fibrosis following injury. The aim of this study was to combine these two therapeutic methods in an attempt to develop a new biological approach to promote efficient healing and recovery of strength after muscle injuries. Our findings indicate that further improvement in the healing of muscle lacerations is attained histologically by the combined administration of IGF-1 to enhance muscle regeneration and decorin to reduce the formation of fibrosis. This improvement was not associated with improved responses to physiological testing, at least at the time-points tested in this study.
骨骼肌能够通过再生进行自我修复。然而,受伤的肌肉往往无法完全恢复其力量,因为完全的肌肉再生会受到纤维化发展的阻碍。目前正在研究通过增强肌肉再生和减少纤维化形成来改善肌肉愈合的生物学方法。此前,我们已经确定胰岛素样生长因子-1(IGF-1)可以改善受伤肌肉的再生。我们还研究了使用抗纤维化剂核心蛋白聚糖来减少损伤后的肌肉纤维化。本研究的目的是将这两种治疗方法结合起来,试图开发一种新的生物学方法,以促进肌肉损伤后的有效愈合和力量恢复。我们的研究结果表明,通过联合使用IGF-1增强肌肉再生和核心蛋白聚糖减少纤维化形成,在组织学上可进一步改善肌肉撕裂伤的愈合。这种改善与生理测试反应的改善无关,至少在本研究测试的时间点上是这样。